Home Self-Collection of Nasal Swabs for Diagnosis of Acute Respiratory Virus Infections in Children With Cystic Fibrosis
Home Self-Collection of Nasal Swabs for Diagnosis of Acute Respiratory Virus Infections in Children With Cystic Fibrosis
复制标题
DOI:
10.1093/jpids/pit039
复制
发表时间:
2013-12-01
影响因子:
3.2
通讯作者:
Campbell, Angela P.
中科院分区:
文献类型:
--
作者:
Emerson, Julia;Cochrane, Elizabeth;Campbell, Angela P.
Background. Understanding the importance of respiratory viruses in children with cystic fibrosis (CF) has been limited because of challenges using clinic-or hospital-based diagnostic testing. We conducted a pilot study to assess feasibility of home self-(or parent-) collection of nasal swabs (NS).Methods. Cystic fibrosis patients aged 6-18 years with new respiratory illness participated. In clinic, a deep nasal flocked swab was collected by research staff and compared with an anterior foam NS obtained after instillation of saline spray. At home, up to 2 self-collections of paired foam NS (with and without saline) were collected and mailed for real-time polymerase chain reaction (PCR) testing.Results. Paired swabs were collected from 28 patients: 18 sets in clinic (deep nasal vs saline foam NS) and 43 sets at home (saline vs dry foam NS) with 9 (50%) and 35 (81%) virus detections, respectively. Home-collected NS were obtained closer to illness onset, with a mean difference in symptom days of -2.3 between home and clinic collections (95% confidence interval [CI] - 3.5, -1.2; P < .001). Rhinovirus comprised 73% of virus detections; the difference in mean PCR cycle threshold values for rhinovirus between swabs collected at home versus clinic was -3.8 (95% CI - 6.8, -0.9; P = .014), indicating significantly higher viral load for home-collected swabs.Conclusions. Home-collected foam NS had a higher positivity rate compared with clinic-collected swabs, likely because collection was closer to illness onset. Home self-collection is feasible and well tolerated for timely respiratory virus diagnosis and provides a novel approach for clinical diagnostics and surveillance of respiratory virus infections among CF patients.